APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Receptor ROR Gamma

Compare research editions
View pricing & licenses

Selected research

Industry Research

Nuclear Receptor ROR Gamma Industry Research Report 2026

19 December 2025139 pages

Choose your research edition.

Industry ResearchNuclear Receptor ROR Gamma Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Receptor ROR Gamma Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Nuclear Receptor ROR Gamma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Receptor ROR Gamma Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Receptor ROR Gamma Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Nuclear Receptor ROR Gamma market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Nuclear Receptor ROR Gamma is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Nuclear Receptor ROR Gamma is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Nuclear Receptor ROR Gamma is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Nuclear Receptor ROR Gamma include Eli Lilly, GlaxoSmithKline Plc, Biogen Inc, Beijing Hanmi Pharmaceutical, Reata Pharmaceuticals Inc, Phenex Pharmaceuticals AG, Pfizer Inc, Lead Pharma Holding BV and Glenmark Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Nuclear Receptor ROR Gamma market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Nuclear Receptor ROR Gamma Market by Company

Eli Lilly

GlaxoSmithKline Plc

Biogen Inc

Beijing Hanmi Pharmaceutical

Reata Pharmaceuticals Inc

Phenex Pharmaceuticals AG

Pfizer Inc

Lead Pharma Holding BV

Glenmark Pharmaceuticals

Genfit SA

Eurofins Advinus

Celgene Corp

Bristol-Myers Squibb Company

Brickell Biotech Inc

Aurigene Discovery Technologies

AbbVie Inc

Nuclear Receptor ROR Gamma Segment by Type

BBI-6000

R&D Progress

INV-17

IMU-366

GSK-2981278

GRC-39815Action

Others

Nuclear Receptor ROR Gamma Segment by Application

Axial Spondyloarthritis

Asthma

Breast Cancer

Chronic Obstructive Pulmonary Disease

Others

Nuclear Receptor ROR Gamma Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Receptor ROR Gamma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Receptor ROR Gamma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Receptor ROR Gamma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Nuclear Receptor ROR Gamma manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Nuclear Receptor ROR Gamma by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Nuclear Receptor ROR Gamma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Nuclear Receptor ROR Gamma Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Nuclear Receptor ROR Gamma Sales (W Units) of Manufacturers (2021-2026) Table 7. Global Nuclear Receptor ROR Gamma Sales Market Share by Manufacturers (2021-2026) Table 8. Global Nuclear Receptor ROR Gamma Revenue of Manufacturers (2021-2026) Table 9. Global Nuclear Receptor ROR Gamma Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Nuclear Receptor ROR Gamma Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Nuclear Receptor ROR Gamma Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Nuclear Receptor ROR Gamma, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Nuclear Receptor ROR Gamma, Product Type & Application Table 14. Global Nuclear Receptor ROR Gamma Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Nuclear Receptor ROR Gamma by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Eli Lilly Company Information Table 19. Eli Lilly Business Overview Table 20. Eli Lilly Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Eli Lilly Nuclear Receptor ROR Gamma Product Portfolio Table 22. Eli Lilly Recent Developments Table 23. GlaxoSmithKline Plc Company Information Table 24. GlaxoSmithKline Plc Business Overview Table 25. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product Portfolio Table 27. GlaxoSmithKline Plc Recent Developments Table 28. Biogen Inc Company Information Table 29. Biogen Inc Business Overview Table 30. Biogen Inc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Biogen Inc Nuclear Receptor ROR Gamma Product Portfolio Table 32. Biogen Inc Recent Developments Table 33. Beijing Hanmi Pharmaceutical Company Information Table 34. Beijing Hanmi Pharmaceutical Business Overview Table 35. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product Portfolio Table 37. Beijing Hanmi Pharmaceutical Recent Developments Table 38. Reata Pharmaceuticals Inc Company Information Table 39. Reata Pharmaceuticals Inc Business Overview Table 40. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product Portfolio Table 42. Reata Pharmaceuticals Inc Recent Developments Table 43. Phenex Pharmaceuticals AG Company Information Table 44. Phenex Pharmaceuticals AG Business Overview Table 45. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product Portfolio Table 47. Phenex Pharmaceuticals AG Recent Developments Table 48. Pfizer Inc Company Information Table 49. Pfizer Inc Business Overview Table 50. Pfizer Inc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Pfizer Inc Nuclear Receptor ROR Gamma Product Portfolio Table 52. Pfizer Inc Recent Developments Table 53. Lead Pharma Holding BV Company Information Table 54. Lead Pharma Holding BV Business Overview Table 55. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product Portfolio Table 57. Lead Pharma Holding BV Recent Developments Table 58. Glenmark Pharmaceuticals Company Information Table 59. Glenmark Pharmaceuticals Business Overview Table 60. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product Portfolio Table 62. Glenmark Pharmaceuticals Recent Developments Table 63. Genfit SA Company Information Table 64. Genfit SA Business Overview Table 65. Genfit SA Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Genfit SA Nuclear Receptor ROR Gamma Product Portfolio Table 67. Genfit SA Recent Developments Table 68. Eurofins Advinus Company Information Table 69. Eurofins Advinus Business Overview Table 70. Eurofins Advinus Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Eurofins Advinus Nuclear Receptor ROR Gamma Product Portfolio Table 72. Eurofins Advinus Recent Developments Table 73. Celgene Corp Company Information Table 74. Celgene Corp Business Overview Table 75. Celgene Corp Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Celgene Corp Nuclear Receptor ROR Gamma Product Portfolio Table 77. Celgene Corp Recent Developments Table 78. Bristol-Myers Squibb Company Company Information Table 79. Bristol-Myers Squibb Company Business Overview Table 80. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product Portfolio Table 82. Bristol-Myers Squibb Company Recent Developments Table 83. Brickell Biotech Inc Company Information Table 84. Brickell Biotech Inc Business Overview Table 85. Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Brickell Biotech Inc Nuclear Receptor ROR Gamma Product Portfolio Table 87. Brickell Biotech Inc Recent Developments Table 88. Aurigene Discovery Technologies Company Information Table 89. Aurigene Discovery Technologies Business Overview Table 90. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product Portfolio Table 92. Aurigene Discovery Technologies Recent Developments Table 93. AbbVie Inc Company Information Table 94. AbbVie Inc Business Overview Table 95. AbbVie Inc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. AbbVie Inc Nuclear Receptor ROR Gamma Product Portfolio Table 97. AbbVie Inc Recent Developments Table 98. Global Nuclear Receptor ROR Gamma Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Nuclear Receptor ROR Gamma Sales by Region (2021-2026) & (W Units) Table 100. Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2021-2026) Table 101. Global Nuclear Receptor ROR Gamma Sales by Region (2027-2032) & (W Units) Table 102. Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2027-2032) Table 103. Global Nuclear Receptor ROR Gamma Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region (2021-2026) Table 105. Global Nuclear Receptor ROR Gamma Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region (2027-2032) Table 107. North America Nuclear Receptor ROR Gamma Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 109. North America Nuclear Receptor ROR Gamma Sales by Country (2027-2032) & (W Units) Table 110. North America Nuclear Receptor ROR Gamma Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Nuclear Receptor ROR Gamma Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Nuclear Receptor ROR Gamma Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 114. Europe Nuclear Receptor ROR Gamma Sales by Country (2027-2032) & (W Units) Table 115. Europe Nuclear Receptor ROR Gamma Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Nuclear Receptor ROR Gamma Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Nuclear Receptor ROR Gamma Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 119. Asia Pacific Nuclear Receptor ROR Gamma Sales by Country (2027-2032) & (W Units) Table 120. Asia Pacific Nuclear Receptor ROR Gamma Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Nuclear Receptor ROR Gamma Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Nuclear Receptor ROR Gamma Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 124. South America Nuclear Receptor ROR Gamma Sales by Country (2027-2032) & (W Units) Table 125. South America Nuclear Receptor ROR Gamma Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Nuclear Receptor ROR Gamma Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Nuclear Receptor ROR Gamma Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 129. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2027-2032) & (W Units) Table 130. Middle East and Africa Nuclear Receptor ROR Gamma Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Nuclear Receptor ROR Gamma Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (W Units) Table 133. Global Nuclear Receptor ROR Gamma Sales by Type (2027-2032) & (W Units) Table 134. Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2021-2026) Table 135. Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2027-2032) Table 136. Global Nuclear Receptor ROR Gamma Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Nuclear Receptor ROR Gamma Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2021-2026) Table 139. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2027-2032) Table 140. Global Nuclear Receptor ROR Gamma Price by Type (2021-2026) & (US$/Unit) Table 141. Global Nuclear Receptor ROR Gamma Price by Type (2027-2032) & (US$/Unit) Table 142. Global Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (W Units) Table 143. Global Nuclear Receptor ROR Gamma Sales by Application (2027-2032) & (W Units) Table 144. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2021-2026) Table 145. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2027-2032) Table 146. Global Nuclear Receptor ROR Gamma Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Nuclear Receptor ROR Gamma Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2021-2026) Table 149. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2027-2032) Table 150. Global Nuclear Receptor ROR Gamma Price by Application (2021-2026) & (US$/Unit) Table 151. Global Nuclear Receptor ROR Gamma Price by Application (2027-2032) & (US$/Unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Nuclear Receptor ROR Gamma Distributors List Table 155. Nuclear Receptor ROR Gamma Customers List Table 156. Nuclear Receptor ROR Gamma Industry Trends Table 157. Nuclear Receptor ROR Gamma Industry Drivers Table 158. Nuclear Receptor ROR Gamma Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Nuclear Receptor ROR Gamma Product Image Figure 5. Global Nuclear Receptor ROR Gamma Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Nuclear Receptor ROR Gamma Market Size (2021-2032) & (US$ Million) Figure 7. Global Nuclear Receptor ROR Gamma Sales (2021-2032) & (W Units) Figure 8. Global Nuclear Receptor ROR Gamma Average Price (US$/Unit) & (2021-2032) Figure 9. BBI-6000 Product Image Figure 10. R&D Progress Product Image Figure 11. INV-17 Product Image Figure 12. IMU-366 Product Image Figure 13. GSK-2981278 Product Image Figure 14. GRC-39815Action Product Image Figure 15. Others Product Image Figure 16. Axial Spondyloarthritis Product Image Figure 17. Asthma Product Image Figure 18. Breast Cancer Product Image Figure 19. Chronic Obstructive Pulmonary Disease Product Image Figure 20. Others Product Image Figure 21. Global Nuclear Receptor ROR Gamma Revenue Share by Manufacturers in 2025 Figure 22. Global Manufacturers of Nuclear Receptor ROR Gamma, Manufacturing Sites & Headquarters Figure 23. Global Top 5 and 10 Nuclear Receptor ROR Gamma Players Market Share by Revenue in 2025 Figure 24. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Global Nuclear Receptor ROR Gamma Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 26. Global Nuclear Receptor ROR Gamma Sales by Region in 2025 Figure 27. Global Nuclear Receptor ROR Gamma Revenue by Region in 2025 Figure 28. North America Nuclear Receptor ROR Gamma Market Size by Country in 2025 Figure 29. North America Nuclear Receptor ROR Gamma Sales Market Share by Country (2021-2032) Figure 30. North America Nuclear Receptor ROR Gamma Revenue Market Share by Country (2021-2032) Figure 31. United States Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Canada Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Europe Nuclear Receptor ROR Gamma Market Size by Country in 2025 Figure 34. Europe Nuclear Receptor ROR Gamma Sales Market Share by Country (2021-2032) Figure 35. Europe Nuclear Receptor ROR Gamma Revenue Market Share by Country (2021-2032) Figure 36. Germany Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. France Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. U.K. Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Italy Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Netherlands Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Nordic Countries Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Nuclear Receptor ROR Gamma Market Size by Country in 2025 Figure 43. Asia Pacific Nuclear Receptor ROR Gamma Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Nuclear Receptor ROR Gamma Revenue Market Share by Country (2021-2032) Figure 45. China Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. China Taiwan Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Nuclear Receptor ROR Gamma Market Size by Country in 2025 Figure 54. South America Nuclear Receptor ROR Gamma Sales Market Share by Country (2021-2032) Figure 55. South America Nuclear Receptor ROR Gamma Revenue Market Share by Country (2021-2032) Figure 56. Mexico Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Brazil Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Nuclear Receptor ROR Gamma Market Size by Country in 2025 Figure 60. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Nuclear Receptor ROR Gamma Revenue Market Share by Country (2021-2032) Figure 62. Turkey Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. UAE Nuclear Receptor ROR Gamma Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2021-2032) Figure 66. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2021-2032) Figure 67. Global Nuclear Receptor ROR Gamma Price (US$/Unit) by Type (2021-2032) Figure 68. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2021-2032) Figure 69. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2021-2032) Figure 70. Global Nuclear Receptor ROR Gamma Price (US$/Unit) by Application (2021-2032) Figure 71. Nuclear Receptor ROR Gamma Value Chain Figure 72. Nuclear Receptor ROR Gamma Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Nuclear Receptor ROR Gamma Industry Opportunities and Challenges

Scope & coverage.

Types
  • BBI-6000
  • R&D Progress
  • INV-17
  • IMU-366
  • GSK-2981278
  • GRC-39815Action
  • Others
Applications
  • Axial Spondyloarthritis
  • Asthma
  • Breast Cancer
  • Chronic Obstructive Pulmonary Disease
  • Others
Companies covered
  • Eli Lilly
  • GlaxoSmithKline Plc
  • Biogen Inc
  • Beijing Hanmi Pharmaceutical
  • Reata Pharmaceuticals Inc
  • Phenex Pharmaceuticals AG
  • Pfizer Inc
  • Lead Pharma Holding BV
  • Glenmark Pharmaceuticals
  • Genfit SA
  • Eurofins Advinus
  • Celgene Corp
  • Bristol-Myers Squibb Company
  • Brickell Biotech Inc
  • Aurigene Discovery Technologies
  • AbbVie Inc

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Nuclear Receptor ROR Gamma Market Size (2021-2032)
  4. 2.2.2 Global Nuclear Receptor ROR Gamma Sales (2021-2032)
  5. 2.2.3 Global Nuclear Receptor ROR Gamma Market Average Price (2021-2032)
  6. 2.3 Nuclear Receptor ROR Gamma by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 BBI-6000
  9. 2.3.3 R&D Progress
  10. 2.3.4 INV-17
  11. 2.3.5 IMU-366
  12. 2.3.6 GSK-2981278
  13. 2.3.7 GRC-39815Action
  14. 2.3.8 Others
  15. 2.4 Nuclear Receptor ROR Gamma by Application
  16. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  17. 2.4.2 Axial Spondyloarthritis
  18. 2.4.3 Asthma
  19. 2.4.4 Breast Cancer
  20. 2.4.5 Chronic Obstructive Pulmonary Disease
  21. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Nuclear Receptor ROR Gamma Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Nuclear Receptor ROR Gamma Sales (W Units) of Manufacturers (2021-2026)
  3. 3.3 Global Nuclear Receptor ROR Gamma Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Nuclear Receptor ROR Gamma Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Nuclear Receptor ROR Gamma Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Nuclear Receptor ROR Gamma, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Nuclear Receptor ROR Gamma, Product Type & Application
  8. 3.8 Global Manufacturers of Nuclear Receptor ROR Gamma, Established Date
  9. 3.9 Global Nuclear Receptor ROR Gamma Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Eli Lilly
  2. 4.1.1 Eli Lilly Company Information
  3. 4.1.2 Eli Lilly Business Overview
  4. 4.1.3 Eli Lilly Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Eli Lilly Nuclear Receptor ROR Gamma Product Portfolio
  6. 4.1.5 Eli Lilly Recent Developments
  7. 4.2 GlaxoSmithKline Plc
  8. 4.2.1 GlaxoSmithKline Plc Company Information
  9. 4.2.2 GlaxoSmithKline Plc Business Overview
  10. 4.2.3 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product Portfolio
  12. 4.2.5 GlaxoSmithKline Plc Recent Developments
  13. 4.3 Biogen Inc
  14. 4.3.1 Biogen Inc Company Information
  15. 4.3.2 Biogen Inc Business Overview
  16. 4.3.3 Biogen Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Biogen Inc Nuclear Receptor ROR Gamma Product Portfolio
  18. 4.3.5 Biogen Inc Recent Developments
  19. 4.4 Beijing Hanmi Pharmaceutical
  20. 4.4.1 Beijing Hanmi Pharmaceutical Company Information
  21. 4.4.2 Beijing Hanmi Pharmaceutical Business Overview
  22. 4.4.3 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product Portfolio
  24. 4.4.5 Beijing Hanmi Pharmaceutical Recent Developments
  25. 4.5 Reata Pharmaceuticals Inc
  26. 4.5.1 Reata Pharmaceuticals Inc Company Information
  27. 4.5.2 Reata Pharmaceuticals Inc Business Overview
  28. 4.5.3 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product Portfolio
  30. 4.5.5 Reata Pharmaceuticals Inc Recent Developments
  31. 4.6 Phenex Pharmaceuticals AG
  32. 4.6.1 Phenex Pharmaceuticals AG Company Information
  33. 4.6.2 Phenex Pharmaceuticals AG Business Overview
  34. 4.6.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product Portfolio
  36. 4.6.5 Phenex Pharmaceuticals AG Recent Developments
  37. 4.7 Pfizer Inc
  38. 4.7.1 Pfizer Inc Company Information
  39. 4.7.2 Pfizer Inc Business Overview
  40. 4.7.3 Pfizer Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Pfizer Inc Nuclear Receptor ROR Gamma Product Portfolio
  42. 4.7.5 Pfizer Inc Recent Developments
  43. 4.8 Lead Pharma Holding BV
  44. 4.8.1 Lead Pharma Holding BV Company Information
  45. 4.8.2 Lead Pharma Holding BV Business Overview
  46. 4.8.3 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product Portfolio
  48. 4.8.5 Lead Pharma Holding BV Recent Developments
  49. 4.9 Glenmark Pharmaceuticals
  50. 4.9.1 Glenmark Pharmaceuticals Company Information
  51. 4.9.2 Glenmark Pharmaceuticals Business Overview
  52. 4.9.3 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product Portfolio
  54. 4.9.5 Glenmark Pharmaceuticals Recent Developments
  55. 4.10 Genfit SA
  56. 4.10.1 Genfit SA Company Information
  57. 4.10.2 Genfit SA Business Overview
  58. 4.10.3 Genfit SA Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Genfit SA Nuclear Receptor ROR Gamma Product Portfolio
  60. 4.10.5 Genfit SA Recent Developments
  61. 4.11 Eurofins Advinus
  62. 4.11.1 Eurofins Advinus Company Information
  63. 4.11.2 Eurofins Advinus Business Overview
  64. 4.11.3 Eurofins Advinus Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Eurofins Advinus Nuclear Receptor ROR Gamma Product Portfolio
  66. 4.11.5 Eurofins Advinus Recent Developments
  67. 4.12 Celgene Corp
  68. 4.12.1 Celgene Corp Company Information
  69. 4.12.2 Celgene Corp Business Overview
  70. 4.12.3 Celgene Corp Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Celgene Corp Nuclear Receptor ROR Gamma Product Portfolio
  72. 4.12.5 Celgene Corp Recent Developments
  73. 4.13 Bristol-Myers Squibb Company
  74. 4.13.1 Bristol-Myers Squibb Company Company Information
  75. 4.13.2 Bristol-Myers Squibb Company Business Overview
  76. 4.13.3 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product Portfolio
  78. 4.13.5 Bristol-Myers Squibb Company Recent Developments
  79. 4.14 Brickell Biotech Inc
  80. 4.14.1 Brickell Biotech Inc Company Information
  81. 4.14.2 Brickell Biotech Inc Business Overview
  82. 4.14.3 Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Brickell Biotech Inc Nuclear Receptor ROR Gamma Product Portfolio
  84. 4.14.5 Brickell Biotech Inc Recent Developments
  85. 4.15 Aurigene Discovery Technologies
  86. 4.15.1 Aurigene Discovery Technologies Company Information
  87. 4.15.2 Aurigene Discovery Technologies Business Overview
  88. 4.15.3 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product Portfolio
  90. 4.15.5 Aurigene Discovery Technologies Recent Developments
  91. 4.16 AbbVie Inc
  92. 4.16.1 AbbVie Inc Company Information
  93. 4.16.2 AbbVie Inc Business Overview
  94. 4.16.3 AbbVie Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 AbbVie Inc Nuclear Receptor ROR Gamma Product Portfolio
  96. 4.16.5 AbbVie Inc Recent Developments
5 Global Nuclear Receptor ROR Gamma Market Scenario by Region
  1. 5.1 Global Nuclear Receptor ROR Gamma Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Nuclear Receptor ROR Gamma Sales by Region: 2021-2032
  3. 5.2.1 Global Nuclear Receptor ROR Gamma Sales by Region: 2021-2026
  4. 5.2.2 Global Nuclear Receptor ROR Gamma Sales by Region: 2027-2032
  5. 5.3 Global Nuclear Receptor ROR Gamma Revenue by Region: 2021-2032
  6. 5.3.1 Global Nuclear Receptor ROR Gamma Revenue by Region: 2021-2026
  7. 5.3.2 Global Nuclear Receptor ROR Gamma Revenue by Region: 2027-2032
  8. 5.4 North America Nuclear Receptor ROR Gamma Market Facts & Figures by Country
  9. 5.4.1 North America Nuclear Receptor ROR Gamma Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Nuclear Receptor ROR Gamma Sales by Country (2021-2032)
  11. 5.4.3 North America Nuclear Receptor ROR Gamma Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Nuclear Receptor ROR Gamma Market Facts & Figures by Country
  15. 5.5.1 Europe Nuclear Receptor ROR Gamma Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Nuclear Receptor ROR Gamma Sales by Country (2021-2032)
  17. 5.5.3 Europe Nuclear Receptor ROR Gamma Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Nuclear Receptor ROR Gamma Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Nuclear Receptor ROR Gamma Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Nuclear Receptor ROR Gamma Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Nuclear Receptor ROR Gamma Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Nuclear Receptor ROR Gamma Market Facts & Figures by Country
  36. 5.7.1 South America Nuclear Receptor ROR Gamma Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Nuclear Receptor ROR Gamma Sales by Country (2021-2032)
  38. 5.7.3 South America Nuclear Receptor ROR Gamma Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.8 Middle East and Africa Nuclear Receptor ROR Gamma Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Nuclear Receptor ROR Gamma Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Nuclear Receptor ROR Gamma Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Nuclear Receptor ROR Gamma Sales by Type (2021-2032)
  2. 6.1.1 Global Nuclear Receptor ROR Gamma Sales by Type (2021-2032) & (W Units)
  3. 6.1.2 Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2021-2032)
  4. 6.2 Global Nuclear Receptor ROR Gamma Revenue by Type (2021-2032)
  5. 6.2.1 Global Nuclear Receptor ROR Gamma Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Nuclear Receptor ROR Gamma Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Nuclear Receptor ROR Gamma Sales by Application (2021-2032)
  2. 7.1.1 Global Nuclear Receptor ROR Gamma Sales by Application (2021-2032) & (W Units)
  3. 7.1.2 Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2021-2032)
  4. 7.2 Global Nuclear Receptor ROR Gamma Revenue by Application (2021-2032)
  5. 7.2.1 Global Nuclear Receptor ROR Gamma Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Nuclear Receptor ROR Gamma Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Nuclear Receptor ROR Gamma Value Chain Analysis
  2. 8.1.1 Nuclear Receptor ROR Gamma Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Nuclear Receptor ROR Gamma Production Mode & Process
  5. 8.2 Nuclear Receptor ROR Gamma Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Nuclear Receptor ROR Gamma Distributors
  8. 8.2.3 Nuclear Receptor ROR Gamma Customers
9 Global Nuclear Receptor ROR Gamma Analyzing Market Dynamics
  1. 9.1 Nuclear Receptor ROR Gamma Industry Trends
  2. 9.2 Nuclear Receptor ROR Gamma Industry Drivers
  3. 9.3 Nuclear Receptor ROR Gamma Industry Opportunities and Challenges
  4. 9.4 Nuclear Receptor ROR Gamma Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst